Facebook
Twitter
Telegram
Report an ErrorKrystal Biotech Financial Statements 2011-2024 | KRYS
Annual Financial Statements Krystal Biotech
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
4.29 B | 2 B | 1.41 B | 1.48 B | 840 M | 256 M | 53.8 M | - | - | - | - | - | - |
Shares |
27.2 M | 25.5 M | 22.2 M | 18.8 M | 15.9 M | 11.2 M | 5.36 M | - | - | - | - | - | - |
Historical Prices |
158 | 78.3 | 63.5 | 78.9 | 53.5 | 22.4 | 10.1 | - | - | - | - | - | - |
Net Income |
10.9 M | -140 M | -69.6 M | -32.2 M | -19.1 M | -10.9 M | -7.92 M | -1.15 M | - | - | - | - | - |
Revenue |
50.7 M | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-110 M | -145 M | -68.3 M | -33 M | -22.1 M | -11.9 M | -4.77 M | -1.14 M | - | - | - | - | - |
Interest Expense |
- | - | 1.49 M | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-105 M | -143 M | -66.4 M | -31.1 M | -21.3 M | -11.8 M | -4.75 M | -1.14 M | - | - | - | - | - |
Operating Expenses |
160 M | 145 M | 68.3 M | 33 M | 22.1 M | 11.9 M | 4.77 M | - | - | - | - | - | - |
General and Administrative Expenses |
98.4 M | 77.7 M | 40.4 M | 15.1 M | 6.46 M | 4.16 M | 1.56 M | 402 K | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Krystal Biotech
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
28.3 M | 28.2 M | 28 M | 26.7 M | 25.7 M | 25.8 M | 25.6 M | 25.5 M | 25.1 M | 25.2 M | 22.2 M | 22.2 M | 21.3 M | 19.7 M | 19.7 M | 18.4 M | 17.4 M | 17.4 M | 17.3 M | 14.5 M | 14.4 M | 14.4 M | 10.6 M | 10.3 M | 10.3 M | 10.3 M | 4.18 M | 3.49 M | 3.49 M | - | 38 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
932 K | - | 80.7 M | -33.2 M | -45.3 M | - | -29.8 M | -28.1 M | -50 M | - | -15.6 M | -16.4 M | -15.8 M | - | -9.61 M | -6.83 M | -5.34 M | - | -4.27 M | -5.35 M | -4.11 M | - | -2.76 M | -2.28 M | -2.15 M | - | -5.27 M | -759 K | -494 K | - | -322 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
45.2 M | - | 8.56 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-6.68 M | - | -26 M | -38 M | -48.8 M | - | -31.5 M | -28.8 M | -50.2 M | - | -15.7 M | -16.4 M | -14.4 M | - | -9.68 M | -6.95 M | -5.95 M | - | -5.34 M | -5.89 M | -4.69 M | - | -2.97 M | -2.45 M | -2.28 M | - | -2.09 M | -715 K | -465 K | - | -322 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | 1.49 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-5.26 M | - | -24.8 M | -36.8 M | -47.7 M | - | -30.8 M | -28.3 M | -49.2 M | - | -13.7 M | -15.2 M | -13.8 M | - | -8.32 M | -6.07 M | -5.53 M | - | -4.59 M | -5.44 M | -4.56 M | - | -2.93 M | -2.43 M | -2.26 M | - | -2.09 M | -712 K | -464 K | - | -322 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
51.9 M | - | 34.5 M | 38 M | 48.8 M | - | 31.5 M | 28.8 M | 50.2 M | - | 15.7 M | 16.4 M | 14.4 M | - | 9.68 M | 6.95 M | 5.95 M | - | 5.34 M | 5.89 M | 4.69 M | - | 2.97 M | 2.45 M | 2.28 M | - | 2.09 M | 715 K | 465 K | - | 322 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
26.1 M | - | 23.7 M | 25.9 M | 24 M | - | 19.9 M | 17.9 M | 15.9 M | - | 9.57 M | 9.8 M | 8.15 M | - | 4.58 M | 3.32 M | 2.42 M | - | 1.46 M | 1.67 M | 1.53 M | - | 1.06 M | 924 K | 757 K | - | 738 K | 269 K | 146 K | - | 81 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency